$ News

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia

Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining

SCORPIUS Holdings shares are trading lower after the company announced that the NYSE will commence delisting proceedings.

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

NYSE American To Commence Delisting Proceedings Against Scorpius Holdings, Inc.

Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives

Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™

Scorpius Holdings Cancels Planned Reverse Stock Split

Scorpius Holdings Announces Reverse Stock Split

Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model

Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability

Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement

Warning: SCPX is at high risk of performing badly

Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually

Scorpius Holdings announces implementation of new cost saving measures

Scorpius Partners with Biotech Firm to Boost U.S. Biomanufacturing Capabilities

Scorpius Holdings Announces Partnership with U.S. Biotech Company

Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats